DEUTSCHE BANK AG\ - NEUROCRINE BIOSCIENCES INC ownership

NEUROCRINE BIOSCIENCES INC's ticker is and the CUSIP is 64125CAD1. A total of 56 filers reported holding NEUROCRINE BIOSCIENCES INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of NEUROCRINE BIOSCIENCES INC
ValueSharesWeighting
Q4 2022$2,522,400
-58.2%
1,600,000
-62.8%
0.00%
-75.0%
Q3 2022$6,033,000
-13.5%
4,300,000
-18.8%
0.00%0.0%
Q2 2022$6,976,000
+10.9%
5,295,000
+10.3%
0.00%
+33.3%
Q1 2022$6,288,000
+5.1%
4,800,0000.0%0.00%0.0%
Q4 2021$5,985,000
+18.8%
4,800,000
+26.3%
0.00%
+50.0%
Q3 2021$5,038,000
-0.8%
3,800,0000.0%0.00%0.0%
Q2 2021$5,080,000
+35.0%
3,800,000
+35.7%
0.00%0.0%
Q1 2021$3,764,000
-2.6%
2,800,0000.0%0.00%0.0%
Q4 2020$3,863,000
+86.3%
2,800,000
+85.7%
0.00%
+100.0%
Q3 2020$2,074,000
-17.3%
1,508,0000.0%0.00%
-50.0%
Q2 2020$2,507,000
-44.5%
1,508,000
-57.2%
0.00%
-50.0%
Q1 2020$4,519,000
-54.1%
3,526,000
-45.2%
0.00%
-33.3%
Q4 2019$9,851,000
+34.1%
6,434,000
+19.9%
0.01%
+20.0%
Q3 2019$7,344,000
-45.3%
5,365,000
-47.5%
0.01%
-37.5%
Q2 2019$13,414,000
-20.8%
10,225,000
-18.4%
0.01%
-20.0%
Q1 2019$16,932,000
+36.4%
12,531,000
+20.5%
0.01%
+11.1%
Q4 2018$12,412,000
-82.8%
10,399,000
-75.4%
0.01%
-57.1%
Q3 2018$72,056,000
+55.6%
42,272,000
+31.8%
0.02%
+61.5%
Q2 2018$46,303,00032,084,0000.01%
Other shareholders
NEUROCRINE BIOSCIENCES INC shareholders Q4 2019
NameSharesValueWeighting ↓
CSS LLC/IL 15,659,000$23,207,6871.52%
SONA ASSET MANAGEMENT (US) LLC 17,500,000$26,317,9521.09%
TENOR CAPITAL MANAGEMENT Co., L.P. 26,765,000$40,113,0990.86%
Warberg Asset Management LLC 1,271,000$1,885,8460.38%
SSI INVESTMENT MANAGEMENT LLC 2,296,000$3,406,1160.28%
Paloma Partners Management Co 3,125,000$4,694,5900.16%
FRANKLIN RESOURCES INC 54,750,000$81,769,1250.04%
Rock Springs Capital Management LP 1,000,000$1,497,9500.04%
LORD, ABBETT & CO. LLC 4,666,000$6,9220.03%
D. E. Shaw & Co., Inc. 14,351,000$21,373,1970.02%
View complete list of NEUROCRINE BIOSCIENCES INC shareholders